Quick Look Drug Book 2009

(11)
Quick Look Drug Book 2009 image
ISBN-10:

0781797160

ISBN-13:

9780781797160

Edition: 1
Released: Jan 01, 2008
Format: Paperback, 1321 pages

Description:

Quick Look Drug Book 2009 includes the most current information on thousands of commonly used drugs, plus a 32-page color insert showing the 200 most commonly prescribed medications. Medical transcriptionists and other healthcare professionals rely on this comprehensive resource for information on brand and generic drug names, pronunciations, look-alike/sound-alike issues, therapeutic categories, dosages, and dosage forms. Exclusive to Quick Look Drug Book is the Indication/Therapeutic Category Index that lists conditions/diseases alphabetically with the drugs used to treat them. Updates include new drugs introduced or approved by the FDA in 2008. Nine appendices are included.

The CD-ROM version has search functions that allow super-fast reference. See CD-ROM listing for details on Quick Look Electronic Drug Reference 2009.

Best prices to buy, sell, or rent ISBN 9780781797160




Related Books

Frequently Asked Questions about Quick Look Drug Book 2009

You can buy the Quick Look Drug Book 2009 book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $19.97 on Amazon and is available from 1 sellers at the moment.

At BookScouter, the prices for the book start at $5.91. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.

If you’re interested in selling back the Quick Look Drug Book 2009 book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Quick Look Drug Book 2009 book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.